Oxidation Products of Uric Acid and Ascorbic Acid in Preterm Infants with Chronic Lung Disease

Publisher： Karger

E-ISSN： 1661-7819|73|1|24-33

ISSN： 1661-7800

Source： Neonatology, Vol.73, Iss.1, 1997-12, pp. : 24-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Dilemmas in Postnatal Steroid Therapy for Chronic Lung Disease in Preterm Infants

By  

Neonatology, Vol. 84, Iss. 1, 2003-07 ,pp. : 96-100

Karger

Access to resources Recommend Favorite

Treating Preterm Infants at Risk for Chronic Lung Disease with Dexamethasone Leads to an Impaired Quality of General Movements

By  

Neonatology, Vol. 82, Iss. 3, 2002-10 ,pp. : 155-158

Karger

Access to resources Recommend Favorite

Early (4–7 Days of Age) Dexamethasone Therapy for Prevention of Chronic Lung Disease in Preterm Infants

By  

Neonatology, Vol. 76, Iss. 5, 1999-10 ,pp. : 283-290

Karger

Access to resources Recommend Favorite

Decreased Use of Postnatal Corticosteroids in Extremely Preterm Infants without Increasing Chronic Lung Disease

By  

Neonatology, Vol. 95, Iss. 2, 2008-09 ,pp. : 172-178

Karger

Access to resources Recommend Favorite

Lung Microvascular Adaptation in Infants with Chronic Lung Disease

By  

Neonatology, Vol. 85, Iss. 4, 2004-06 ,pp. : 273-282

Karger

Access to resources Recommend Favorite